117 related articles for article (PubMed ID: 9754868)
1. Sirolimus (rapamycin, Rapamune) and combination therapy with cyclosporin A in the rat developing adjuvant arthritis model: correlation with blood levels and the effects of different oral formulations.
Carlson RP; Hartman DA; Ochalski SJ; Zimmerman JL; Glaser KB
Inflamm Res; 1998 Aug; 47(8):339-44. PubMed ID: 9754868
[TBL] [Abstract][Full Text] [Related]
2. Combination of cyclosporine A and calcitriol in the treatment of adjuvant arthritis.
Boissier MC; Chiocchia G; Fournier C
J Rheumatol; 1992 May; 19(5):754-7. PubMed ID: 1613705
[TBL] [Abstract][Full Text] [Related]
3. Effect of immunostimulatory ribomunyl on the preventive treatment of rat adjuvant arthritis with cyclosporine and methotrexate.
Rovensky J; Svík K; Stancíková M; Istok R
J Rheumatol; 2003 Sep; 30(9):2027-32. PubMed ID: 12966611
[TBL] [Abstract][Full Text] [Related]
4. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
5. Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat.
Bohra R; Schöning W; Klawitter J; Brunner N; Schmitz V; Shokati T; Lawrence R; Arbelaez MF; Schniedewind B; Christians U; Klawitter J
PLoS One; 2012; 7(10):e48063. PubMed ID: 23118926
[TBL] [Abstract][Full Text] [Related]
6. Enzyme and combination therapy with cyclosporin A in the rat developing adjuvant arthritis.
Rovenská E; Svík K; Stancíková M; Rovenský J
Int J Tissue React; 1999; 21(4):105-11. PubMed ID: 10761540
[TBL] [Abstract][Full Text] [Related]
7. Preclinical results of sirolimus treatment in transplant models.
Stepkowski SM
Transplant Proc; 2003 May; 35(3 Suppl):219S-226S. PubMed ID: 12742499
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin, a potential disease-modifying antiarthritic drug.
Carlson RP; Hartman DA; Tomchek LA; Walter TL; Lugay JR; Calhoun W; Sehgal SN; Chang JY
J Pharmacol Exp Ther; 1993 Aug; 266(2):1125-38. PubMed ID: 8355184
[TBL] [Abstract][Full Text] [Related]
9. Antihyperalgesic and antiallodynic effect of sirolimus in rat model of adjuvant arthritis.
Orhan CE; Önal A; Uyanıkgil Y; Ülker S
Eur J Pharmacol; 2013 Apr; 705(1-3):35-41. PubMed ID: 23461852
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood.
Barten MJ; Streit F; Boeger M; Dhein S; Tarnok A; Shipkova M; Armstrong VW; Mohr FW; Oellerich M; Gummert JF
Transplantation; 2004 Apr; 77(8):1154-62. PubMed ID: 15114077
[TBL] [Abstract][Full Text] [Related]
11. Effect of FTY720, a novel immunosuppressant, on adjuvant-induced arthritis in rats.
Matsuura M; Imayoshi T; Chiba K; Okumoto T
Inflamm Res; 2000 Aug; 49(8):404-10. PubMed ID: 11028757
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interactions between sirolimus and microemulsion cyclosporine when orally administered jointly and 4 hours apart in healthy volunteers.
Zimmerman JJ; Harper D; Getsy J; Jusko WJ
J Clin Pharmacol; 2003 Oct; 43(10):1168-76. PubMed ID: 14517200
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients.
Felipe CR; Park SI; Pinheiro-Machado PG; Garcia R; Casarini DE; Moreira S; Tedesco-Silva H; Medina-Pestana JO
Fundam Clin Pharmacol; 2009 Oct; 23(5):625-31. PubMed ID: 19656203
[TBL] [Abstract][Full Text] [Related]
14. Effect of early phase adjuvant arthritis on hepatic P450 enzymes and pharmacokinetics of verapamil: an alternative approach to the use of an animal model of inflammation for pharmacokinetic studies.
Ling S; Jamali F
Drug Metab Dispos; 2005 Apr; 33(4):579-86. PubMed ID: 15659540
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection.
Longoria J; Roberts RF; Marboe CC; Stouch BC; Starnes VA; Barr ML
J Thorac Cardiovasc Surg; 1999 Apr; 117(4):714-8. PubMed ID: 10096966
[TBL] [Abstract][Full Text] [Related]
17. Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis.
Bendele AM; Chlipala ES; Scherrer J; Frazier J; Sennello G; Rich WJ; Edwards CK
Arthritis Rheum; 2000 Dec; 43(12):2648-59. PubMed ID: 11145022
[TBL] [Abstract][Full Text] [Related]
18. Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis.
Badger AM; Blake SM; Dodds RA; Griswold DE; Swift BA; Rieman DJ; Stroup GB; Hoffman SJ; Gowen M
J Pharmacol Exp Ther; 1999 Dec; 291(3):1380-6. PubMed ID: 10565864
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
20. In vivo effect of pinosylvin and pterostilbene in the animal model of adjuvant arthritis.
Macickova T; Drabikova K; Nosal R; Bauerova K; Mihalova D; Harmatha J; Pecivova J
Neuro Endocrinol Lett; 2010; 31 Suppl 2():91-5. PubMed ID: 21187826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
